Latest filing published 15 Jun 2015 for Genasys Inc., €14k.
Insider track record
No signal scores available.
Closed purchases
Based on 5 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- -29.9%Entry US$1.34 · Close at T+365 US$0.94
- +250.0%Entry US$0.44 · Close at T+365 US$1.52
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Katherine H. Mcdermott: trading record in brief
Katherine H. Mcdermott is a declared insider of Genasys Inc., with filings sourced from SEC (Form 4). In total, 39 filings cover trades dated from 12 December 2008 to 15 June 2015.
On the open market, the record shows 5 purchases worth €10k and 27 sales worth €272k. The net balance comes to €261k on the selling side. Open-market purchases are the filings investors watch most closely, because the insider pays for the shares out of pocket. Other entries cover 7 option exercises. 2015 to date brings no purchases and 20 sales.
A typical purchase (the median) is worth €2,431. For 5 purchases whose 90-day window has closed, the share price was higher on day 90 than the day after publication in 60% of cases, with a median move of +86.4%. These figures describe past trades and do not predict future prices.
Most recently, on 15 June 2015, the filings show an option exercise worth €14k in Genasys Inc. The last insider purchase was made public on 21 May 2012, 5,285 days ago. Filings reach the SEC (Form 4) feed a median of 2 days after the trade. The legal deadline for a Form 4 is two business days after the transaction. Sales are harder to read than purchases, since they often meet personal needs such as tax or diversification. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Katherine H. Mcdermott
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 12,779 shares@ US$1.24Common StockSEC:0001437749-15-012334:0
- 200 shares@ US$2.32Common StockSEC:0001437749-15-012334:1
- 200 shares@ US$2.31Common StockSEC:0001437749-15-012334:2
- 1,636 shares@ US$2.30Common StockSEC:0001437749-15-012334:3
- 4,003 shares@ US$2.29Common StockSEC:0001437749-15-012334:4
- 4,500 shares@ US$2.28Common StockSEC:0001437749-15-012334:5
- 1,840 shares@ US$2.25Common StockSEC:0001437749-15-012334:6
- 400 shares@ US$2.26Common StockSEC:0001437749-15-012334:7
- 30,698 shares@ US$1.24Common StockSEC:0001437749-15-012334:8
- 500 shares@ US$2.25Common tockSEC:0001437749-15-012334:9
- 15,168 shares@ US$2.24Common StockSEC:0001437749-15-012334:10
- 110 shares@ US$2.24Common StockSEC:0001437749-15-012334:11
- 6,241 shares@ US$2.23Common StockSEC:0001437749-15-012334:12
- 200 shares@ US$2.23Common StockSEC:0001437749-15-012334:13
- 3,000 shares@ US$2.22Common StockSEC:0001437749-15-012334:14
- 92 shares@ US$2.22Common StockSEC:0001437749-15-012334:15
- 2,325 shares@ US$2.21Common StockSEC:0001437749-15-012334:16
- 31,523 shares@ US$1.24Common StockSEC:0001437749-15-012334:17
- 4,600 shares@ US$2.20Common StockSEC:0001437749-15-012334:18
- 17,740 shares@ US$2.21Common StockSEC:0001437749-15-012334:19
- 200 shares@ US$2.22Common StockSEC:0001437749-15-012334:20
- 692 shares@ US$2.24Common StockSEC:0001437749-15-012334:21
- 100 shares@ US$2.25Common StockSEC:0001437749-15-012334:22
- 25,000 shares@ US$1.24Common StockSEC:0001437749-14-016201:0
- 25,000 shares@ US$3.30Common StockSEC:0001437749-14-016201:1
25 of 39 declarations